A 6-Day Losing Streak Has Bunge Global Stock Down 15%
A multi-day slide in Bunge Global stock has pushed its valuation below the market median, prompting a closer look at its growth story.
A recent losing streak in Bunge Global (BG) has erased about $3.6 billion from the company’s market value. The stock has now moved lower for 6 consecutive trading days, producing a cumulative loss of 15% for shareholders over that period.
This kind of sustained move in one direction often forces investors to re-evaluate a stock’s story against its price.
BG Versus The S&P 500, Streak And Beyond
Here is how BG stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | BG | S&P 500 |
|---|---|---|
| 1D | -2.5% | 1.7% |
| 6D (Current Streak) | -15.2% | -0.8% |
| 1M (21D) | -1.6% | -0.8% |
| 3M (63D) | -16.3% | 4.2% |
| YTD 2026 | 19.3% | 8.6% |
| 2025 | 18.6% | 16.4% |
| 2024 | -20.7% | 23.3% |
| 2023 | 3.8% | 24.2% |
What does the data say about this drop?
The sell-off appears to be specific to the company. Over the same 6 trading days, the S&P 500 returned -0.8%, suggesting the streak is mostly this stock’s own story. Such streaks are not rare; currently, 36 S&P 500 stocks are on losing streaks of 3 days or more.
Fundamentally, the company’s recent growth has been significant, with revenue over the last twelve months growing 80.5% against an S&P 500 median of 7.8%. While its operating margin of 2.3% is below the S&P 500 median of 18.4%, the stock now trades at a price-to-earnings multiple of 20.2, which is less than the S&P 500 median of 24.0. The market appears to be weighing weaker margins against much faster growth and a lower valuation.
How should an investor treat a streak?
A streak is information, not an instruction. It tells you where momentum and market attention have been focused, but it doesn’t tell you where the price will go next. The disciplined response is to use the streak as a trigger to check the facts.
It is an opportunity to compare the underlying business to its new, lower price. The data on the company’s growth and valuation relative to the market provides a clear starting point for that assessment.
A slide like this always poses the same follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
And for anyone who would rather own the whole group than one company’s story, a consumer staples ETF like XLP owns the whole group. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and emotions priced at market open are expensive.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the rules do the flinching for you.